Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic Syndrome) - Pipeline Review, H1 2019

Published	Pages	Publisher	Report code
Jan 2019	96	Global Markets Direct	ASDR-478942

Published: Jan 2019 - Pages : 96 - Publisher : Global Markets Direct - Report code : ASDR-478942

Achillion Pharmaceuticals Inc
Akari Therapeutics Plc
Alexion Pharmaceuticals Inc
Amgen Inc
ChemoCentryx Inc
Greenovation Biotech GmbH
Omeros Corp
Ra Pharmaceuticals Inc

Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

This report can be of interest as well:

Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic Syndrome) Drugs in Development by Stages, ...

Published: March, 2022 | Report code: ASDR-599078